MILI's Executive in Residence Program invites highly accomplished leaders from the public, private, or nonprofit sector to enhance the academic environment of MILI by sharing their professional expertise. Our executive in residence professionals share their expertise by participating in activities such as teaching, interacting with the University and business community, advising, as well as generating ideas to help further the mission of MILI.
He teaches the required Healthcare Marketplace course for MILI and is one of the instructors for the Medical Industry Valuation Laboratory.
Dr. Finch is widely known for his work on the cost, quality and financing of health care in the public and private market and is nationally recognized has as an expert in research methods and evaluation. Finch has been a principal on over a dozen federally sponsored grants and contracts, including HCFA’s National Post Acute Care project, the Second Generation Social HMO demonstration, the NIMH funded Youth Development Survey and the NIA funded Evaluation of the Medicaid Demonstration.
He has conducted major studies on the effects of surgical volume on outcomes in hospitals, guideline performance for diabetes, the cost and financing of end of life care and hospital safety. His latest book explores the role of physician communication in health care.
Paul Gam is Managing Director, Grace Associates, LLC, a strategic advisory firm that specializes in guiding medical technology companies and investors in the assessment, development, and execution of commercialization, growth and liquidity strategies. Mr. Gam is also co-founder and chairman of Zurich Medical Inc., which develops proprietary cardiac and vascular devices that are easier and more cost effective to use, and are designed specifically to serve health care environments that are resource constrained.
Mr. Gam was Vice President, International Development for St. Jude Medical (NYSE: STJ), a Fortune 500 medical devices company, where he led mergers & acquisitions, developed strategic alliances, and drove other business development initiatives for the $3 billion International Division from 2002 to 2011. He established the company's first Wholly Owned Foreign Enterprise in China and served as its Chairman of the Board.
From 1997 to 2002, Mr. Gam served at Medtronic (NYSE: MDT), the world's largest medical technology company, where he was Director of Finance for the Cardiac Rhythm Disease Management business, and then head of Global Internal Audit.
Mr. Gam serves on the National Advisory Committee of the Robert Wood Johnson Foundation Executive Nurse Fellows Program. He was the Chairman of the Minnesota World Trade Center and advisor to Minnesota gubernatorial international trade missions. He served on the Minnesota Commission on Judicial Selection and the Board on Judicial Standards. Under his leadership as Chapter President, Minnesota was twice awarded Best Chapter of the Year by the Organization of Chinese Americans, a national organization dedicated to advancing the social, political, and economic well-being of Asian-Pacific Americans in the United States. Mr. Gam served on the Professional Ethics Committee of the Minnesota Society of CPAs, and was also the Finance Chairman of the successful re-election campaign of Minnesota Governor Arne Carlson.
Mr. Gam is a W.K. Kellogg National Fellow, a Salzburg Global Fellow, and a Bush Foundation Leadership Fellow. He was the recipient of the Minneapolis/St. Paul Business Journal Minority Business Executive Award, the CityBusiness 40 Under 40 Award and the Twin Cities International Citizen Award.
Mr. Gam is a graduate of Queen's College in Hong Kong where the Father of Modern China Dr. Sun Yat-sen was an alumnus. He earned a Bachelor of Science in Accounting and a Master of Business Administration at the University of Minnesota Carlson School of Management.
Mr. Gam and his wife Queenie have three children and reside in Saint Paul, Minnesota.
Thomas Gunderson is a managing director and senior research analyst at Piper Jaffray, following medical technology companies. In more than 20 years as an analyst, Gunderson has been recognized by several industry publications, including The Wall Street Journal, Institutional Investor, Thomson Reuters and First Call. Most recently he was named by StarMine as the 2014 "No. 1 Stock Picker in Health Care Equipment & Supplies." He is on the Board of Directors for the Minneapolis Heart Institute Foundation, a member of the AHA's Science and Technology Accelerator Committee, and a member of the National Industry Council for the Medical Industry Leadership Institute at the University of Minnesota, and has served on the local chapter of the American Heart Association's Executive Leadership Team and on the Board of Directors for the Children's Hospitals of Minnesota Foundation. Gunderson holds a bachelor's degree from Carleton College and graduate degrees in cell biology and business administration.
Vice President, Marketing
Vital, A Toshiba Medical Systems Group Company
Julie Kemp, Vice President, Marketing joined Vital in December, 2013. Ms. Kemp leads all aspects of global marketing within Vital, including product management, commercialization, medical education programs, and marketing communication. Ms. Kemp has over 15 years of cross-functional marketing experience at both Medtronic and GE Healthcare, with her most recent role leading Global Market Development for the Cardiac Rhythm and Diagnostics Division at Medtronic. During her earlier professional career, she managed global pre-market clinical trials and was a field clinical engineer. Ms. Kemp earned her Bachelor of Science in Biomedical Engineering from the University of Minnesota, and her Master in Business Administration from the Carlson School of Management at the University of Minnesota.
Bill is a senior healthcare executive and consultant with extensive experience in strategy formulation, physician integration, campus development, service line formation and operational performance. Bill held numerous leadership positions in the HealthEast system in Minnesota; most of his 20 years working at St John’s Hospital achieving the role of Vice President/Administrator. His numerous consulting projects in hospital and senior services include developing/implementing: a neurologist/hospital call system, a medical tourism hospital, senior living campus, geriatric physician practice, payer contracting for a national primary clinic group, critical access hospital strategic plans and has served as an advisor to medical device startup companies. Currently Bill is developing a virtual ACO in rural Minnesota ,CEO of a Care Choice Cooperative , owner of a wound care startup and partner in an physician practice and consulting group for post- acute services. Bill has a Master’s in Business Administration and a Bachelor of Arts in Psychology.
Randall Nelson is founder and President of Evergreen Medical Technologies, Inc., a contract development and manufacturing company for medical devices located in St. Paul, MN. Mr. Nelson is also President of PhysioTest, an independent test lab providing contract testing services for medical devices.
Mr. Nelson has been responsible for the development of medical devices for over 30 years at both emerging and larger medical device companies. Mr. Nelson has held management positions at St. Jude Medical Inc., Boston Scientific Corporation, Angeion Corporation; and Cardiac Pacemakers, Inc.
Mr. Nelson has 13 issued patents in the field of medical devices. He has a Mechanical Engineering degree from the University of Minnesota and an Economics degree from Willamette University in Salem, Oregon. From 2009-2015, Mr. Nelson was an Adjunct Faculty member of the Carlson School of Management, University of Minnesota, where he taught a graduate level course in the valuation of new medical innovations.
Dale retired from Medtronic in 2006 after 24 years. Most recently he served as V.P. of CRDM Venture Programs. Prior to this he served as VP/GM of the CRDM Therapy Delivery business. Before Medtronic, he held management and sales positions at Litton Microwave and Burroughs Corporation and managed a clean technology start-up company.
From 2006 until May of 2014 he served as the President and CEO for LifeScience Alley and The BioBusiness Alliance of Minnesota. From 2007 until 2009 Dale led efforts to develop a long-term strategy called Destination 2025 that focuses on the development and growth of high potential biology based industries in the state of MN. From 2011 until 2013 he served as the Founding Executive Director of the Medical Device Innovation Consortium (MDIC), a public private partnership between the FDA and the medical device industry with a mission to enhance the productivity of the medical device eco-system within the United States.
Today he is the President and CEO of Act 3, LLC, a consulting, engineering, and investment firm that focuses on helping companies to expand their global markets, assisting start up companies, and providing unique program management services in the development of capabilities that extend across public and private sectors. Act 3 has established an experienced global network of professionals that can be leveraged to meet the needs of virtually any high knowledge content company ranging from an early stage startup to fortune 500 global enterprises.